Page 1

Liva Nova Health innovation that matters NEWS RELEASE LivaNova Reports First Quarter 2021 Results London , April 28 , 2021 LivaNova PLC ( NASDAQ : LIVN ) , a market - leading medical technology and innovation company , today reported results for the quarter ended March 31 , 2021 . For the first quarter of 2021 , worldwide sales from continuing operations were $ 247.6 million , an increase of 2.1 percent on a reported basis and a decline of 0.4 percent on a constant - currency ¹ basis , as compared to the same quarter of the previous year . On the basis of U.S. Generally Accepted Accounting Principles ( GAAP ) , first quarter 2021 diluted loss per share from continuing operations was $ 0.61 . First quarter 2021 adjusted diluted earnings per share from continuing operations was $ 0.35 . " Epilepsy sales growth in the quarter reflects improving market dynamics , especially in the United States . The pace of vaccination efforts , along with patients ' and their caregivers ' willingness to seek treatment , is key to the continued recovery of the Epilepsy business , " said Damien McDonald , Chief Executive Officer of LivaNova . " We expect the recovery to continue from here and develop into more consistent sales and EPS growth in the second half of the year . We remain focused on delivering growth in our core , achieving pipeline milestones and executing on initiatives to improve profitability and cash generation . " ¹Constant - currency percent change is a non - GAAP metric . For an explanation of this and other non - GAAP metrics used in this release , please see the section entitled " Use of Non - GAAP Financial Measures . " For reconciliations of certain non - GAAP metrics , please see the tables that accompany the press release . 1